Page last updated: 2024-11-02

palmidrol and Idiopathic Pulmonary Fibrosis

palmidrol has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.

Research Excerpts

ExcerptRelevanceReference
"Idiopathic pulmonary fibrosis was induced in male mice by a single intratracheal administration of saline with bleomycin sulphate (1mg/kg body weight) in a volume of 100μL."1.43Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis. ( Cordaro, M; Crupi, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Fusco, R; Impellizzeri, D; Siracusa, R, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Paola, R1
Impellizzeri, D1
Fusco, R1
Cordaro, M1
Siracusa, R1
Crupi, R1
Esposito, E1
Cuzzocrea, S1

Other Studies

1 other study available for palmidrol and Idiopathic Pulmonary Fibrosis

ArticleYear
Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis.
    Pharmacological research, 2016, Volume: 111

    Topics: Amides; Animals; Biomarkers; Bleomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Dr

2016